Market Closed -
Japan Exchange
02:00:00 2024-04-26 am EDT
5-day change
1st Jan Change
585
JPY
-0.68%
+1.21%
-10.69%
Tranche Update on Medical Data Vision Co., Ltd.'s Equity Buyback Plan announced on March 16, 2021.
March 25, 2021 at 02:30 am EDT
From March 16, 2021 to March 24, 2021, the company has repurchased 229,100 shares, representing 0.58% for ¥499.89 million. With this, the company has completed the repurchase of 229,100 shares, representing 0.58% for ¥499.89 million under the buyback announced on March 16, 2021.
Medical Data Vision Co., Ltd. Provides Dividend Guidance for the Year Ending December 31, 2024
Feb. 13
CI
Medical Data Vision Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2024
Feb. 13
CI
SBI Holdings, Inc. agreed to acquire additional 5.35% minority stake in Medical Data Vision Co., Ltd..
23-08-24
CI
Medical Data Vision Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2023
23-08-10
CI
Medical Data Vision Co., Ltd. Provides Dividend Guidance for the Year Ending December 31, 2023
23-08-10
CI
Medical Data Vision Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
23-05-11
CI
Medical Data Vision Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2023
23-05-11
CI
Medical Data Vision Co., Ltd. Provides Dividend Guidance for the Year Ending December 31, 2023
23-05-11
CI
Medical Data Vision Co., Ltd. Provides Dividend Guidance for the Year Ending December 31, 2023
23-02-13
CI
Medical Data Vision Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2023
23-02-13
CI
Jefferies Adjusts Medical Data Vision’s Price Target to 960 Yen From 1,040 Yen, Keeps at Hold
23-02-02
MT
Medical Data Vision Co., Ltd. acquired 50% stake in AIR BIOS Co., Ltd. from Hitoshi Kobayashi, Hajime Kuboshima and others.
22-12-30
CI
Medical Data Vision Co., Ltd. Provides Dividend Guidance for the Year Ending December 31, 2022
22-11-14
CI
Medical Data Vision Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2022
22-11-14
CI
Jefferies Starts Medical Data Vision at Hold With 1,040 Yen Price Target
22-10-12
MT
Prospection Partners with Medical Data Vision Co., Ltd. to Improve Treatment Access for Patients
22-09-05
CI
Medical Data Vision Provides Dividend Guidance for the Fiscal Year Ending December 31, 2022
22-08-08
CI
Medical Data Vision Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2022
22-08-08
CI
Medical Data Vision Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2022
22-05-12
CI
Medical Data Vision Co., Ltd. Announces Dividend for the Fiscal Year Ended December 31, 2021, Payable on March 30, 2022; Provides Dividend Guidance for the Fiscal Year Ending December 31, 2022
22-02-14
CI
Medical Data Vision Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2022
22-02-14
CI
Medical Data Vision Co., Ltd. agreed to acquire 50% of stake in AIR BIOS Co., Ltd. from Hitoshi Kobayashi, Hajime Kuboshima and others.
22-02-13
CI
Tranche Update on Medical Data Vision Co., Ltd.'s Equity Buyback Plan announced on December 22, 2021.
22-01-26
CI
Medical Data Vision Co., Ltd.'s Equity Buyback announced on December 22, 2021, has closed with 800,000 shares, representing 2.05% for ¥906.61 million.
22-01-24
CI
Tranche Update on Medical Data Vision Co., Ltd.'s Equity Buyback Plan announced on December 22, 2021.
22-01-04
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Medical Data Vision Co.,Ltd. is a company engaged in the medical data network business. The Data Network Service provides management support systems for medical institutions and health insurance unions, as well as EVE, Medical Code and CADA-BOX for hospitals. The Data Utilization Service provides corporate services and personal services based on the medical and health information accumulated through the data network services, various analysis data to pharmaceutical companies, research institutes, patients and consumers. The segment provides various services, such as MDV analyzer, ADHOC research service, OTC, H&BC and insurance company services, as well as Media logs and others.
More about the company
Average target price
710
JPY
Spread / Average Target
+21.37%
Consensus
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
MEDICAL DATA VISION CO., LTD. 
